[1]赵国阳.重视实验室检查在骨质疏松性骨折诊疗中的应用——《骨质疏松性骨折中医诊疗指南》解读[J].中医正骨,2023,35(12):1-4.
点击复制

重视实验室检查在骨质疏松性骨折诊疗中的应用——《骨质疏松性骨折中医诊疗指南》解读()
分享到:

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第35卷
期数:
2023年12期
页码:
1-4
栏目:
指南解读
出版日期:
2023-12-20

文章信息/Info

作者:
赵国阳
江苏大学附属医院,江苏 镇江 212001
关键词:
骨质疏松性骨折 实验室检查 指南
摘要:
骨质疏松性骨折是骨质疏松症最为严重的并发症。实验室检查是骨质疏松性骨折诊疗过程中的重要内容,在骨质疏松性骨折的鉴别诊断、潜在致病因素识别、治疗决策制定以及临床疗效评估等方面发挥了重要作用。《骨质疏松性骨折中医诊疗指南》(以下简称《指南》)针对骨质疏松性骨折诊疗过程中的实验室检查给出了明确的指导性意见,临床实用性很强。本文从骨质疏松性骨折的实验室检查项目、实验室检查在骨质疏松性骨折诊疗中的应用两个方面对《指南》进行了解读,以期其能更好地服务于临床、教学和科研工作。

参考文献/References:

[1] 中华中医药学会.骨质疏松性骨折中医诊疗指南[J].中医正骨,2023,35(1):1-9.
[2] LEWIECKI E M.Evaluating patients for secondary causes of osteoporosis[J].Curr Osteoporos Rep,2022,20(1):1-12.
[3] BELAYA Z,ROZHINSKAYA L,DEDOV I,et al.A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis[J].Osteoporos Int,2023,34(3):429-447.
[4] 孟迅吾,周学瀛.协和代谢性骨病学[M].北京:中国协和医科大学出版社,2020:749.
[5] 《中国骨质疏松杂志》骨代谢专家组.骨代谢生化指标临床应用专家共识(2023修订版)[J].中国骨质疏松杂志,2023,29(4):469-476.
[6] 张萌萌.骨代谢实验室诊断[M].北京:化学工业出版社,2020:54-55.
[7] LI X P,LI X Y,YANG M H,et al.Changes of bone turnover markers after elderly hip fracture surgery[J].J Bone Miner Metab,2021,39(2):237-244.
[8] 中华医学会骨质疏松和骨矿盐疾病分会.骨转换生化标志物临床应用指南[J].中华骨质疏松和骨矿盐疾病杂志,2021,14(4):321-336.
[9] 张萌萌,徐又佳,侯建明,等.骨质疏松实验室诊断及影响因素专家共识2022[J].中国骨质疏松杂志,2022,9(28):1249-1259.
[10] PAINTER S E,KLEEREKOPER M,CAMACHO P M.Secondary osteoporosis:a review of the recent evidence[J].EndocrPract,2006,12(4):436-445
[11] 梁玉龙,陈涛,富斌,等.不同中医体质体积骨密度及骨代谢指标的定量分析[J].中医学报,2023,38(8):1758-1764.
[12] 廖文强.老年原发性骨质疏松症中医证型与骨代谢指标的相关性研究[D].福州:福建中医药大学,2022.
[13] 张奇.原发性骨质疏松症患者中医体质类型与骨代谢指标的相关性研究[D].广州:广州中医药大学,2020.
[14] JAVAID M K,SAMIA,LEMS W,et al.A patient level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement:a position paper of the IOF Capture the Fracture Working Group,National Osteoporosis Foundation and Fragility Fracture Network[J].Osteoporos Int,2020,31(7):1193-1204.
[15] 林巧璇,刘晶,卢莉铭,等.补肾活血汤对骨质疏松性椎体压缩性骨折PKP术后患者疼痛和骨代谢的影响[J].中国中医骨伤科杂志,2021,29(3):21-26.
[16] 侯伟,万趸,张旭,等.抗骨质疏松胶囊治疗胸腰椎骨质疏松性压缩骨折的临床疗效观察[J].四川中医,2023,41(6):159-162.
[17] 沈凯,尹永涛.自拟地萸生髓汤对老年骨质疏松性椎体压缩性骨折PKP术后患者的影响[J].医学理论与实践,2022,35(12):2066-2068.
[18] 蘧冰,侯钦云,张晶华.骨疏松方治疗老年骨质疏松症临床效果研究[J].实用医院临床杂志,2023,20(2):92-95.
[19] 赖明星,邢利威,赵冬,等.针灸对原发性骨质疏松症骨代谢影响的研究概述[J].辽宁中医杂志,2020,47(12):207-211.
[20] HUANG R,XU S,LI D,et al.Acupoint injection treatment for primary osteoporosis:a systematic review and meta-analysis of randomized controlled trials protocol[J].Medicine,2019,98(32):e16735.
[21] 落乐,何成文,孙大连,等.手法复位对骨质疏松症性椎体压缩骨折患者骨代谢水平、生化指标影响的研究[J].湖北中医药大学学报,2021,23(2):101-104.
[22] MLGLIORINI F,MAFFULLI N,SPIEZIA F,et al.Biomarkers as therapy monitoring for postmenopausal osteoporosis:a systematic review[J].J OrthopSurg Res,2021,16(1):318.
[23] SHIGDEL R,OSIMA M,AHMED L A,et al.Bone turnover markers are associated with higher cortical porosity,thinner cortices,and larger size of the proximal femur and non-vertebral fractures[J].Bone,2015,81:1-6.
[24] IVASKA K K, MCGUIGAN F E, MALMGREN L,et al.Bone turnover marker profiling and fracture risk in older women:fracture risk from age 75 to 90[J].Calcif Tissue Int,2022,111(3):288-299.
[25] IVASKA K K,GERDHEM P,VAANANEN H K,et al.Bone turnover markers and prediction of fracture:a prospective follow-up study of 1040 elderly women for a mean of 9 years[J].J Bone Miner Res,2010,25(2):393-403.
[26] VILACA T,GOSSIEL F,EASTELL R.Bone turnover markers:use in fracture prediction[J].J Clin Densitom,2017,20(3):346-352.

相似文献/References:

[1]潘雄,刘其顺,应行,等.中药联合4步康复锻炼法对骨质疏松性椎体压缩 骨折患者生存质量的影响[J].中医正骨,2015,27(04):65.
[2]宋永枝,陈双玲.唑来膦酸静脉滴注联合鲑降钙素肌肉注射治疗 骨质疏松性长骨骨折[J].中医正骨,2016,28(01):70.
[3]吴鹏,王博,孔令成,等.强骨饮颗粒联合阿仑膦酸钠维D3片口服在原发性骨质疏松性髋部骨折术后抗骨质疏松治疗中的应用[J].中医正骨,2016,28(05):16.
 WU Peng,WANG Bo,KONG Lingcheng,et al.Oral application of Qiangguyin Keli(强骨饮颗粒)and alendronate sodium Vitamin D3 tablets in postoperative anti-osteoporosis treatment in patients with primary osteoporotic hip fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(12):16.
[4]陈建德,樊晓琦,夏炳江,等.球囊扩张部位对椎体后凸成形术治疗骨质疏松性椎体压缩骨折疗效及安全性的影响[J].中医正骨,2017,29(02):11.
 CHEN Jiande,FAN Xiaoqi,XIA Bingjiang,et al.Influence of balloon dilation position on curative effect and safety of percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(12):11.
[5]史晓林,王健,王博,等.脆性骨折的防治进展[J].中医正骨,2017,29(05):20.
[6]陈勍,刘钟,陈文亮,等.股骨近端防旋髓内钉固定联合口服仙灵骨葆胶囊治疗肾阳虚型骨质疏松性股骨转子间骨折[J].中医正骨,2017,29(07):69.
[7]曾武,林曙峰,朱俊峰,等.女性骨质疏松性桡骨远端骨折锁定钢板内固定术后腕关节功能恢复的影响因素分析[J].中医正骨,2017,29(08):39.
 ZENG Wu,LIN Shufeng,ZHU Junfeng,et al.Analysis of factors influencing wrist function recovery after locking plate internal fixation for treatment of osteoporotic distal radius fractures in female[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(12):39.
[8]丁志清,颜峰,喻灿明,等.椎体后凸成形术后非典型骨水泥植入综合征死亡1例[J].中医正骨,2017,29(11):76.
[9]俞兴,王婷,杨济洲,等.经皮椎体成形术和经皮椎体后凸成形术治疗Kmmell病的对比研究[J].中医正骨,2018,30(06):23.
 YU Xing,WANG Ting,YANG Jizhou,et al.A retrospective trial of percutaneous vertebroplasty versus percutaneous kyphoplasty for treatment of Kmmell's diseases[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(12):23.
[10]彭小东,张晓刚,赵文韬,等.有限元分析在过伸复位治疗骨质疏松性椎体压缩性骨折生物力学研究中的应用进展[J].中医正骨,2018,30(07):25.

备注/Memo

备注/Memo:
基金项目:江苏省卫生健康委2022年度医学科研立项项目(M2022019); 骨质疏松和骨矿盐疾病中青年医生优才培养计划暨白求恩·石药骨质疏松科研基金项目
通讯作者:赵国阳 E-mail:zgy996600@163.com
更新日期/Last Update: 1900-01-01